I. Hypothesis
Treatment of children during surgery employing cardiopulmonary bypass with inhaled, exogenous nitric oxide (iNO) delivered to the cardiopulmonary bypass circuit will:
1. Modulate ischemia/reperfusion injury
2. Influence endothelial dysfunction
3. Ameliorate the bypass-triggered